Hui Hu
Impact in
- Rehabilitation top 5%
- Wound Healing and Treatments
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
Papers in
-
- Extracellular vesicles in disease 4
- Gut microbiota and health 4
- Angiogenesis and VEGF in Cancer 3
-
- Nanoplatforms for cancer theranostics 5
- Co-authors
- Yu Chen (6 shared papers)Wei Feng (4 shared papers)Yuehua Li (4 shared papers)Xiaoqin Qian (4 shared papers)Xiuguo Han (1 shared paper)Meiqi Chang (1 shared paper)Li Sheng Ding (1 shared paper)Huijing Xiang (1 shared paper)
- Journals
- Frontiers in Pediatrics (2 papers)Chemical Engineering Journal (2 papers)Frontiers in Microbiology (1 paper)mSystems (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Hui Hu
31 papers receiving 1.5k citations
Hui Hu's Hit Papers
Peers
Comparison fields: 5 of 91
- Rehabilitation 76
- Biomedical Engineering 432
- Materials Chemistry 365
- Biomaterials 87
- Molecular Biology 391
Countries citing papers authored by Hui Hu
This map shows the geographic impact of Hui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Hu more than expected).
Fields of papers citing papers by Hui Hu
This network shows the impact of papers produced by Hui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Hu. The network helps show where Hui Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases Hit paper breakdown → | 2021 | 470 |
| 2 | Emerging Nanomedicine‐Enabled/Enhanced Nanodynamic Therapies beyond Traditional Photodynamics Hit paper breakdown → | 2021 | 235 |
| 3 | 2020 | 120 | |
| 4 | 2016 | 86 | |
| 5 | 2022 | 82 | |
| 6 | 2019 | 79 | |
| 7 | Gut–X axis Hit paper breakdown → | 2025 | 66 |
| 8 | 2022 | 60 | |
| 9 | 2019 | 55 | |
| 10 | 2021 | 34 | |
| 11 | 2019 | 33 | |
| 12 | 2018 | 30 | |
| 13 | Comparison of endothelial cell- and endothelial progenitor cell-derived exosomes in promoting vascular endothelial cell repair. | 2019 | 21 |
| 14 | 2022 | 16 | |
| 15 | 2021 | 14 | |
| 16 | 2024 | 14 | |
| 17 | 2020 | 11 | |
| 18 | 2024 | 10 | |
| 19 | 2020 | 7 | |
| 20 | 2020 | 6 |
About Hui Hu
Hui Hu is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Genetics and Infectious Diseases, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Extracellular vesicles in disease (4 papers), Gut microbiota and health (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Chemokine receptors and signaling (2 papers) and Blood Coagulation and Thrombosis Mechanisms (1 paper). The work is most often cited by research in Rehabilitation (76 citations), Biomedical Engineering (432 citations), Materials Chemistry (365 citations), Biomaterials (87 citations) and Molecular Biology (391 citations). Hui Hu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Yu Chen, Wei Feng, Yuehua Li, Xiaoqin Qian, Xiuguo Han, Meiqi Chang, Li Sheng Ding, Huijing Xiang, Yuehua Li and Jungong Zhao. Their work appears in journals such as Frontiers in Pediatrics, Chemical Engineering Journal, Frontiers in Microbiology, mSystems and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.